Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Eun-Ju Ko & Sang-Moo Kang. (2018) Immunology and efficacy of MF59-adjuvanted vaccines. Human Vaccines & Immunotherapeutics 14:12, pages 3041-3045.
Read now
Read now
Jesus Zepeda-Cervantes & Luis Vaca. (2018) Induction of adaptive immune response by self-aggregating peptides. Expert Review of Vaccines 17:8, pages 723-738.
Read now
Read now
Christopher A. Seid, Kathryn M. Jones, Jeroen Pollet, Brian Keegan, Elissa Hudspeth, Molly Hammond, Junfei Wei, C. Patrick McAtee, Leroy Versteeg, Amanda Gutierrez, Zhuyun Liu, Bin Zhan, Jonathan L. Respress, Ulrich Strych, Maria Elena Bottazzi & Peter J. Hotez. (2017) Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease. Human Vaccines & Immunotherapeutics 13:3, pages 621-633.
Read now
Read now
David A Johnson. (2013) TLR4 agonists as vaccine adjuvants: a chemist’s perspective. Expert Review of Vaccines 12:7, pages 711-713.
Read now
Read now
Articles from other publishers (27)
Gang Hu, David J. Varisco, Sayan Das, C. Russell Middaugh, Francesca Gardner, Robert K. Ernst, Wendy L. Picking & William D. Picking. (2023) Physicochemical characterization of biological and synthetic forms of two lipid A-based TLR4 agonists. Heliyon 9:7, pages e18119.
Crossref
Crossref
Archana Gopalakrishnan, Katharina Richard, Rezwanul Wahid, Regina Harley, Marcelo B. Sztein, Lynn D. Hawkins & Stefanie N. Vogel. (2022) E6020, a TLR4 Agonist Adjuvant, Enhances Both Antibody Titers and Isotype Switching in Response to Immunization with Hapten-Protein Antigens and Is Diminished in Mice with TLR4 Signaling Insufficiency. The Journal of Immunology 209:10, pages 1950-1959.
Crossref
Crossref
Jing Jie, Guomu Liu, Jingyue Feng, Desheng Huo, Yixuan Wu, Hongyan Yuan, Guixiang Tai & Weihua Ni. (2022) MF59 Promoted the Combination of CpG ODN1826 and MUC1-MBP Vaccine-Induced Antitumor Activity Involved in the Enhancement of DC Maturation by Prolonging the Local Retention Time of Antigen and Down-Regulating of IL-6/STAT3. International Journal of Molecular Sciences 23:18, pages 10887.
Crossref
Crossref
Sabna Kotta, Abdul Wadood Kha, Shahid H. Ansari, Rakesh Kumar Shar, Y.T. Kamal, Hibah Mubarak Al, Nabil Abdulhafiz, Sanjula Baboota & Javed Ali. (2022) Efavirenz nanoemulsion: Formulation Optimization by Box-Behnken Design, in vivo Pharmacokinetic Evaluation and Stability Assessment. International Journal of Pharmacology 18:4, pages 732-745.
Crossref
Crossref
Jatin Machhi, Farah Shahjin, Srijanee Das, Milankumar Patel, Mai Mohamed Abdelmoaty, Jacob D. Cohen, Preet Amol Singh, Ashish Baldi, Neha Bajwa, Raj Kumar, Lalit K. Vora, Tapan A. Patel, Maxim D. Oleynikov, Dhruvkumar Soni, Pravin Yeapuri, Insiya Mukadam, Rajashree Chakraborty, Caroline G. Saksena, Jonathan Herskovitz, Mahmudul Hasan, David Oupicky, Suvarthi Das, Ryan F. Donnelly, Kenneth S. Hettie, Linda Chang, Howard E. Gendelman & Bhavesh D. Kevadiya. (2021) Nanocarrier vaccines for SARS-CoV-2. Advanced Drug Delivery Reviews 171, pages 215-239.
Crossref
Crossref
Liliana E. Villanueva‐Lizama, Julio V. Cruz‐Chan, Leroy Versteeg, Christian F. Teh‐Poot, Kristyn Hoffman, April Kendricks, Brian Keegan, Jeroen Pollet, Fabian Gusovsky, Peter J. Hotez, Maria Elena Bottazzi & Kathryn M. Jones. (2020)
TLR4 agonist protects against
Trypanosoma cruzi
acute lethal infection by decreasing cardiac parasite burdens
. Parasite Immunology 42:10.
Crossref
Crossref
Nadeem Ullah, Ling Hao, Yaqi Wu, Yandi Zhang, Qing Lei, Jo-Lewis Banga Ndzouboukou, Xiaosong Lin & Xionglin Fan. (2020)
Differential Immunogenicity and Protective Efficacy Elicited by MTO- and DMT-Adjuvanted CMFO Subunit Vaccines against
Mycobacterium tuberculosis
Infection
. Journal of Immunology Research 2020, pages 1-8.
Crossref
Crossref
Katharina Richard, Darren J. Perkins, Erin M. Harberts, Yang Song, Archana Gopalakrishnan, Kari Ann Shirey, Wendy Lai, Alexandra Vlk, Anup Mahurkar, Shreeram Nallar, Lynn D. Hawkins, Robert K. Ernst & Stefanie N. Vogel. (2020) Dissociation of TRIF bias and adjuvanticity. Vaccine 38:27, pages 4298-4308.
Crossref
Crossref
Leroy Versteeg, Junfei Wei, Zhuyun Liu, Brian Keegan, Ricardo T. Fujiwara, Kathryn M. Jones, Oluwatoyin Asojo, Ulrich Strych, Maria Elena Bottazzi, Peter J. Hotez & Bin Zhan. (2020) Protective immunity elicited by the nematode-conserved As37 recombinant protein against Ascaris suum infection. PLOS Neglected Tropical Diseases 14:2, pages e0008057.
Crossref
Crossref
Thomas Ebensen, Barbara Fuchs, Kai Schulze & Carlos Alberto Guzmán. 2020. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids
285
315
.
Meagan A. Barry, Leroy Versteeg, Qian Wang, Jeroen Pollet, Bin Zhan, Fabian Gusovsky, Maria Elena Bottazzi, Peter J. Hotez & Kathryn M. Jones. (2019) A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection. PLOS Neglected Tropical Diseases 13:5, pages e0007413.
Crossref
Crossref
Thomas Ebensen, Barbara Fuchs, Kai Schulze & Carlos Alberto Guzmán. 2018. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids
1
31
.
Saeed Nazeri, Sedigheh Zakeri, Akram A. Mehrizi, Navid D. Djadid, Georges Snounou, Chiara Andolina & François Nosten. (2018) Vaccine adjuvants CpG (oligodeoxynucleotides ODNs), MPL (3-O-deacylated monophosphoryl lipid A) and naloxone-enhanced Th1 immune response to the Plasmodium vivax recombinant thrombospondin-related adhesive protein (TRAP) in mice. Medical Microbiology and Immunology 207:5-6, pages 271-286.
Crossref
Crossref
Rushit N. Lodaya, Luis A. Brito, Tom Y.H. Wu, Andrew T. Miller, Gillis R. Otten, Manmohan Singh & Derek T. O'Hagan. (2018) Stable Nanoemulsions for the Delivery of Small Molecule Immune Potentiators. Journal of Pharmaceutical Sciences 107:9, pages 2310-2314.
Crossref
Crossref
Emilie Seydoux, Hong Liang, Natasha Dubois Cauwelaert, Michelle Archer, Nicholas D. Rintala, Ryan Kramer, Darrick Carter, Christopher B. Fox & Mark T. Orr. (2018) Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses. The Journal of Immunology 201:1, pages 98-112.
Crossref
Crossref
Agnese Donadei, Cristiana Balocchi, Maria R. Romano, Luigi Panza, Roberto Adamo, Francesco Berti, Derek T. O'Hagan, Simona Gallorini & Barbara C. Baudner. (2017) Optimizing adjuvants for intradermal delivery of MenC glycoconjugate vaccine. Vaccine 35:32, pages 3930-3937.
Crossref
Crossref
Jeroen Pollet, Leroy Versteeg, Wanderson Rezende, Ulrich Strych, Fabian Gusovsky, Peter J. Hotez & Maria Elena Bottazzi. (2017) A simple fluorescence-based assay for quantification of the Toll-Like Receptor agonist E6020 in vaccine formulations. Vaccine 35:10, pages 1410-1416.
Crossref
Crossref
C.B. Fox, D. Carter, R.M. Kramer, A.M. Beckmann & S.G. Reed. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
105
127
.
Jean Haensler, Patricia Probeck, Jin Su, Fabienne Piras, François Dalençon, Jean-François Cotte, Véronique Chambon, Shehzad M. Iqbal, Lynn Hawkins & Nicolas Burdin. (2015) Design and preclinical characterization of a novel vaccine adjuvant formulation consisting of a synthetic TLR4 agonist in a thermoreversible squalene emulsion. International Journal of Pharmaceutics 486:1-2, pages 99-111.
Crossref
Crossref
Mi-Gyeong Kim, Joo Yeon Park, Yuna Shon, Gunwoo Kim, Gayong Shim & Yu-Kyoung Oh. (2014) Nanotechnology and vaccine development. Asian Journal of Pharmaceutical Sciences 9:5, pages 227-235.
Crossref
Crossref
Benoît Levast, Sunita Awate, Lorne Babiuk, George Mutwiri, Volker Gerdts & Sylvia van Drunen Littel-van den Hurk. (2014) Vaccine Potentiation by Combination Adjuvants. Vaccines 2:2, pages 297-322.
Crossref
Crossref
Alexis García & Juan B. De Sanctis. (2014) An overview of adjuvant formulations and delivery systems. APMIS 122:4, pages 257-267.
Crossref
Crossref
Steven G Reed, Mark T Orr & Christopher B Fox. (2013) Key roles of adjuvants in modern vaccines. Nature Medicine 19:12, pages 1597-1608.
Crossref
Crossref
Francesco Berti & Roberto Adamo. (2013) Recent Mechanistic Insights on Glycoconjugate Vaccines and Future Perspectives. ACS Chemical Biology 8:8, pages 1653-1663.
Crossref
Crossref
Ernesto Oviedo-Orta, Chris Ka-Fai Li & Rino Rappuoli. (2013) Perspectives on vaccine development for the elderly. Current Opinion in Immunology 25:4, pages 529-534.
Crossref
Crossref
Julie S Lefebvre & Laura Haynes. (2013) Vaccine strategies to enhance immune responses in the aged. Current Opinion in Immunology 25:4, pages 523-528.
Crossref
Crossref
Luis A. Brito, Padma Malyala & Derek T. O’Hagan. (2013) Vaccine adjuvant formulations: A pharmaceutical perspective. Seminars in Immunology 25:2, pages 130-145.
Crossref
Crossref